PDB14 Assessing Treatment Success of Diabetes Therapies - Number Needed to Treat to Reach a Clinically Relevant Composite Endpoint- Using a Meta-Analysis of the Liraglutide Clinical Trial Program
Jun 1, 2012, 00:00
10.1016/j.jval.2012.03.935
https://www.valueinhealthjournal.com/article/S1098-3015(12)01000-5/fulltext
Title :
PDB14 Assessing Treatment Success of Diabetes Therapies - Number Needed to Treat to Reach a Clinically Relevant Composite Endpoint- Using a Meta-Analysis of the Liraglutide Clinical Trial Program
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)01000-5&doi=10.1016/j.jval.2012.03.935
First page :
A173
Section Title :
Diabetes/Endocrine Disorders
Open access? :
No
Section Order :
431